According to #TechSci Research report, Global Coronavirus Vaccine Market is expected to rise in 2021 and 2022 in value terms to reach USD91325.46 million in 2021.
Learn More - https://bit.ly/3qmxDOw
Visit our website @ https://www.techsciresearch.com/
For more market research news visit our blog: https://techsciblog.com/
PowerPoint Presentation
GLOBAL CORONAVIRUS VACCINE MARKET
FORECAST & OPPORTUNITIES
2016 – 2026
MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
Scope of Report
Product of Interest (POI): Coronavirus Vaccine
Review Period
2016 – 2019
Base Year
2020
Estimated Year
2021
Forecast Period
2022 – 2026
Year Range
A COVID‑19 vaccine is a vaccine intended to provide acquired
immunity against severe acute respiratory syndrome coronavirus 2
(SARS‑CoV‑2), the virus that causes coronavirus disease 2019
(COVID‑19). The COVID‑19 vaccines are widely celebrated for their
role in reducing the spread, severity, and death caused by
COVID-19.
Market Segmentation
REGION
Europe
North America
South America
Middle East & Africa
Asia Pacific
PRODUCT TYPE
Monovalent Vaccine
Multivariant Vaccine
VACCCINE TYPE
Virus Vaccine
Viral Vector Vaccine
Nucleic Acid Vaccine
Protein Based Vaccine
Others
INFECTION TYPE
SARS-CoV-2
SARS-CoV
MERS-CoV
ROUTE OF ADMINISTRATION
Intramuscular
Oral
Intranasal
PATIENT TYPE
Adult
Pediatric
END USER
Hospitals
Clinics
Research Institutes
Others
Table of Contents
S. No.ContentsPage No.1.Product Overview (Definition of product
and major terminologies used in the report)2.Research Methodology
(Detailed description of the methodology used to conduct the
research, Raw data backup, list of all secondary sources, List of
respondents for primary surveys)3.Impact of COVID-19 on Global
Coronavirus Vaccine Market4.Executive Summary (This chapter covers
summary of the complete study.)5.Voice of Customer5.1.Brand
Awareness5.2.Vaccine Efficacy5.3.Patient Satisfaction
Analysis5.4.Post-Vaccination Side Effects6.Global Coronavirus
Vaccine Market Outlook, 2016-2026F (This chapter includes a brief
overview of the product of interest market such as total market’s
growth rate, expected growth rate, key growth levers, leading
region, top grossing product Type, etc. It includes more of a
qualitative information about the market.)6.1.Market Size &
Forecast6.1.1.By Value6.2.Market Share & Forecast6.2.1.By
Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV)6.2.2.By Vaccine
Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine,
Protein Based Vaccine, Others)6.2.3.By Product Type (Monovalent
Vaccine v/s Multivariant Vaccine)6.2.4.By Route of Administration
(Intramuscular, Oral, Intranasal6.2.5.By Patient Type (Adult v/s
Pediatric)6.2.6.By End User (Hospitals, Clinics, Research
Institutes, Others)6.2.7.By Company (2020)6.2.8.By Region
6.3.Market Map
Table of Contents
S. No.ContentsPage No.7.Asia-Pacific Coronavirus Vaccine Market
Outlook7.1.Market Size & Forecast7.1.1.By Value7.2.Market Share
& Forecast7.2.1.By Infection Type7.2.2.By Vaccine Type7.2.3.By
Product Type7.2.4.By Route of Administration7.2.5.By Patient
Type7.2.6.By End User7.2.7.By Country 7.3.Asia-Pacific: Country
Analysis7.3.1.China Coronavirus Vaccine Market
Outlook7.3.1.1.Market Size & Forecast7.3.1.1.1.By
Value7.3.1.2.Market Share & Forecast7.3.1.2.1.By Infection
Type7.3.1.2.2.By Vaccine Type7.3.1.2.3.By Product Type7.3.1.2.4.By
Route of Administration7.3.1.2.5.By Patient Type7.3.1.2.6.By End
User7.3.2.India Coronavirus Vaccine Market Outlook7.3.2.1.Market
Size & Forecast
Table of Contents
S. No.ContentsPage No.7.3.2.1.1.By Value7.3.2.2.Market Share
& Forecast7.3.2.2.1.By Infection Type7.3.2.2.2.By Vaccine
Type7.3.2.2.3.By Product Type7.3.2.2.4By Route of
Administration7.3.2.2.5.By Patient Type7.3.2.2.6.By End
User7.3.3.Australia Coronavirus Vaccine Market
Outlook7.3.3.1.Market Size & Forecast7.3.3.1.1.By
Value7.3.3.2.Market Share & Forecast7.3.3.2.1.By Infection
Type7.3.3.2.2.By Vaccine Type7.3.3.2.3.By Product Type7.3.3.2.4.By
Route of Administration7.3.3.2.5.By Patient Type7.3.3.2.6.By End
User7.3.4.Japan Coronavirus Vaccine Market Outlook7.3.4.1.Market
Size & Forecast7.3.4.1.1.By Value7.3.4.2.Market Share &
Forecast7.3.4.2.1.By Infection Type7.3.4.2.2.By Vaccine Type
Table of Contents
S. No.ContentsPage No.7.3.4.2.3.By Product Type7.3.4.2.4By Route
of Administration7.3.4.2.5.By Patient Type7.3.4.2.6.By End
User7.3.5.South Korea Coronavirus Vaccine Market
Outlook7.3.5.1.Market Size & Forecast7.3.5.1.1.By
Value7.3.5.2.Market Share & Forecast7.3.5.2.1.By Infection
Type7.3.5.2.2.By Vaccine Type7.3.5.2.3.By Product Type7.3.5.2.4.By
Route of Administration7.3.5.2.5.By Patient Type7.3.5.2.6.By End
User7.3.6.Hong Kong Coronavirus Vaccine Market
Outlook7.3.6.1.Market Size & Forecast7.3.6.1.1.By
Value7.3.6.2.Market Share & Forecast7.3.6.2.1.By Infection
Type7.3.6.2.2.By Vaccine Type
Table of Contents
S. No.ContentsPage No.7.3.6.2.3.By Product Type7.3.6.2.4By Route
of Administration7.3.6.2.5.By Patient Type7.3.6.2.6.By End
User7.3.7.Singapore Coronavirus Vaccine Market
Outlook7.3.7.1.Market Size & Forecast7.3.7.1.1.By
Value7.3.7.2.Market Share & Forecast7.3.7.2.1.By Infection
Type7.3.7.2.2.By Vaccine Type7.3.7.2.3.By Product Type7.3.7.2.4.By
Route of Administration7.3.7.2.5.By Patient Type7.3.7.2.6.By End
User7.3.8.Thailand Coronavirus Vaccine Market Outlook7.3.8.1.Market
Size & Forecast7.3.8.1.1.By Value7.3.8.2.Market Share &
Forecast7.3.8.2.1.By Infection Type7.3.8.2.2.By Vaccine
Type7.3.8.2.3.By Product Type7.3.8.2.4.By Route of
Administration7.3.8.2.5.By Patient Type7.3.8.2.6.By End User
Table of Contents
S. No.ContentsPage No.8.Europe Coronavirus Vaccine Market
Outlook8.1.Market Size & Forecast8.1.1.By Value8.2.Market Share
& Forecast8.2.1.By Infection Type8.2.2.By Vaccine Type8.2.3.By
Product Type8.2.4.By Route of Administration8.2.5.By Patient
Type8.2.6.By End User8.2.7.By Country 8.3.Europe: Country
Analysis8.3.1.France Coronavirus Vaccine Market
Outlook8.3.1.1.Market Size & Forecast8.3.1.1.1.By
Value8.3.1.2.Market Share & Forecast8.3.1.2.1.By Infection
Type8.3.1.2.2.By Vaccine Type8.3.1.2.3.By Product Type8.3.1.2.4.By
Route of Administration8.3.1.2.5.By Patient Type8.3.1.2.6.By End
User
Table of Contents
S. No.ContentsPage No.8.3.2.Germany Coronavirus Vaccine Market
Outlook8.3.2.1.Market Size & Forecast8.3.2.1.1.By
Value8.3.2.2.Market Share & Forecast8.3.2.2.1.By Infection
Type8.3.2.2.2.By Vaccine Type8.3.2.2.3.By Product Type8.3.2.2.4By
Route of Administration8.3.2.2.5.By Patient Type8.3.2.2.6.By End
User8.3.3.United Kingdom Coronavirus Vaccine Market
Outlook8.3.3.1.Market Size & Forecast8.3.3.1.1.By
Value8.3.3.2.Market Share & Forecast8.3.3.2.1.By Infection
Type8.3.3.2.2.By Vaccine Type8.3.3.2.3.By Product Type8.3.3.2.4.By
Route of Administration8.3.3.2.5.By Patient Type8.3.3.2.6.By End
User
Table of Contents
S. No.ContentsPage No.8.3.4.Italy Coronavirus Vaccine Market
Outlook8.3.4.1.Market Size & Forecast8.3.4.1.1.By
Value8.3.4.2.Market Share & Forecast8.3.4.2.1.By Infection
Type8.3.4.2.2.By Vaccine Type8.3.4.2.3.By Product Type8.3.4.2.4By
Route of Administration8.3.4.2.5.By Patient Type8.3.4.2.6.By End
User8.3.5.Spain Coronavirus Vaccine Market Outlook8.3.5.1.Market
Size & Forecast8.3.5.1.1.By Value8.3.5.2.Market Share &
Forecast8.3.5.2.1.By Infection Type8.3.5.2.2.By Vaccine
Type8.3.5.2.3.By Product Type8.3.5.2.4.By Route of
Administration8.3.5.2.5.By Patient Type8.3.5.2.6.By End User
Table of Contents
S. No.ContentsPage No.9.North America Coronavirus Vaccine Market
Outlook9.1.Market Size & Forecast9.1.1.By Value9.2.Market Share
& Forecast9.2.1.By Infection Type9.2.2.By Vaccine Type9.2.3.By
Product Type9.2.4.By Route of Administration9.2.5.By Patient
Type9.2.6.By End User9.2.7.By Country 9.3.North America: Country
Analysis9.3.1.United States Coronavirus Vaccine Market
Outlook9.3.1.1.Market Size & Forecast9.3.1.1.1.By
Value9.3.1.2.Market Share & Forecast9.3.1.2.1.By Infection
Type9.3.1.2.2.By Vaccine Type9.3.1.2.3.By Product Type9.3.1.2.4.By
Route of Administration9.3.1.2.5.By Patient Type9.3.1.2.6.By End
User
Table of Contents
S. No.ContentsPage No.9.3.2.Mexico Coronavirus Vaccine Market
Outlook9.3.2.1.Market Size & Forecast9.3.2.1.1.By
Value9.3.2.2.Market Share & Forecast9.3.2.2.1.By Infection
Type9.3.2.2.2.By Vaccine Type9.3.2.2.3.By Product Type9.3.2.2.4By
Route of Administration9.3.2.2.5.By Patient Type9.3.2.2.6.By End
User9.3.3.Canada Coronavirus Vaccine Market Outlook9.3.3.1.Market
Size & Forecast9.3.3.1.1.By Value9.3.3.2.Market Share &
Forecast9.3.3.2.1.By Infection Type9.3.3.2.2.By Vaccine
Type9.3.3.2.3.By Product Type9.3.3.2.4.By Route of
Administration9.3.3.2.5.By Patient Type9.3.3.2.6.By End User
Table of Contents
S. No.ContentsPage No.10.South America Coronavirus Vaccine
Market Outlook10.1.Market Size & Forecast10.1.1.By
Value10.2.Market Share & Forecast10.2.1.By Infection
Type10.2.2.By Vaccine Type10.2.3.By Product Type10.2.4.By Route of
Administration10.2.5.By Patient Type10.2.6.By End User10.2.7.By
Country 10.3.South America: Country Analysis10.3.1.Brazil
Coronavirus Vaccine Market Outlook10.3.1.1.Market Size &
Forecast10.3.1.1.1.By Value10.3.1.2.Market Share &
Forecast10.3.1.2.1.By Infection Type10.3.1.2.2.By Vaccine
Type10.3.1.2.3.By Product Type10.3.1.2.4.By Route of
Administration10.3.1.2.5.By Patient Type10.3.1.2.6.By End User
Table of Contents
S. No.ContentsPage No.10.3.2.Argentina Coronavirus Vaccine
Market Outlook10.3.2.1.Market Size & Forecast10.3.2.1.1.By
Value10.3.2.2.Market Share & Forecast10.3.2.2.1.By Infection
Type10.3.2.2.2.By Vaccine Type10.3.2.2.3.By Product
Type10.3.2.2.4By Route of Administration10.3.2.2.5.By Patient
Type10.3.2.2.6.By End User10.3.3.Colombia Coronavirus Vaccine
Market Outlook10.3.3.1.Market Size & Forecast10.3.3.1.1.By
Value10.3.3.2.Market Share & Forecast10.3.3.2.1.By Infection
Type10.3.3.2.2.By Vaccine Type10.3.3.2.3.By Product
Type10.3.3.2.4.By Route of Administration10.3.3.2.5.By Patient
Type10.3.3.2.6.By End User
Table of Contents
S. No.ContentsPage No.11.Middle East and Africa Coronavirus
Vaccine Market Outlook11.1.Market Size & Forecast11.1.1.By
Value11.2.Market Share & Forecast11.2.1.By Infection
Type11.2.2.By Vaccine Type11.2.3.By Product Type11.2.4.By Route of
Administration11.2.5.By Patient Type11.2.6.By End User11.2.7.By
Country 11.3.Middle East and Africa: Country Analysis11.3.1.South
Africa Coronavirus Vaccine Market Outlook11.3.1.1.Market Size &
Forecast11.3.1.1.1.By Value11.3.1.2.Market Share &
Forecast11.3.1.2.1.By Infection Type11.3.1.2.2.By Vaccine
Type11.3.1.2.3.By Product Type11.3.1.2.4.By Route of
Administration11.3.1.2.5.By Patient Type11.3.1.2.6.By End User
Table of Contents
S. No.ContentsPage No.11.3.2.Saudi Arabia Coronavirus Vaccine
Market Outlook11.3.2.1.Market Size & Forecast11.3.2.1.1.By
Value11.3.2.2.Market Share & Forecast11.3.2.2.1.By Infection
Type11.3.2.2.2.By Vaccine Type11.3.2.2.3.By Product
Type11.3.2.2.4By Route of Administration11.3.2.2.5.By Patient
Type11.3.2.2.6.By End User11.3.3.UAE Coronavirus Vaccine Market
Outlook11.3.3.1.Market Size & Forecast11.3.3.1.1.By
Value11.3.3.2.Market Share & Forecast11.3.3.2.1.By Infection
Type11.3.3.2.2.By Vaccine Type11.3.3.2.3.By Product
Type11.3.3.2.4.By Route of Administration11.3.3.2.5.By Patient
Type11.3.3.2.6.By End User
Table of Contents
S. No.ContentsPage No.11.3.4.Kuwait Coronavirus Vaccine Market
Outlook11.3.4.1.Market Size & Forecast11.3.4.1.1.By
Value11.3.4.2.Market Share & Forecast11.3.4.2.1.By Infection
Type11.3.4.2.2.By Vaccine Type11.3.4.2.3.By Product
Type11.3.4.2.4.By Route of Administration11.3.4.2.5.By Patient
Type11.3.4.2.6.By End User12.Market Dynamics (This chapter assesses
the major demand drivers and
restraints.)12.1.Drivers12.2.Challenges13.Market Trends &
Developments (This section captures recent trends pertaining to
manufacturing or consumption, market movements in terms of points
of production and consumption, advancements and
development)14.Competitive Landscape 14.1.Competition
Outlook14.2.Global Players Profiled (Leading Companies)14.2.1.
Company DetailsCompany Details14.2.2. Products &
ServicesProducts & Services14.2.3. Financials (As
Reported)Financials (As Reported)14.2.4. Key Market Focus &
Geographical PresenceKey Market Focus & Geographical
Presence
Table of Contents
S. No.ContentsPage No.14.2.5. Recent Developments14.2.6. Key
Management Personnel15.Strategic Recommendations (Based on the
findings of the report strategic recommendations on how to enter
and expand market share)16.About Us & Disclaimer
Research Methodology
Identifying Key Opinion Leaders
Questionnaire Design
In-depth Interviews
Data Collection
Developing List of Respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary research was conducted to determine top
players in the global coronavirus vaccine market, overall market
size and segmental market size.
In order to conduct industry experts’ interviews, TechSci
formulated a detailed discussion guide.
List of industry players and industry specialists was
developed.
TechSci conducted interviews with industry experts and industry
players for data collection and verification.
Data obtained as a result of primary and secondary research was
validated through rigorous triangulation.
The data was scrutinized using MS-Excel, statistical tools and
internal proprietary database to obtain qualitative and
quantitative insights about the global coronavirus vaccine
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research
Desk Research
Company Analysis
Recent Developments
Market Changing Aspects/Dynamics
Government Policies
Conclusion
Market Participants
Key Strengths
LinkedIn
TechSci Internal Database
Factiva
Hoovers
Paid Sources
Company Websites
Company Annual Reports
White Paper Study
Financial Reports
Investor Presentations
Regulatory Body
Associations, etc.
Secondary Research
Primary Research
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and
analyzed various aspects of the global coronavirus vaccine market.
The team has analyzed the outlook of various segments of this
market, while considering the major influencing factors such as
increase use of coronavirus vaccine. The study includes market
forecasting, which would enable our clients to take better
decisions while planning their strategy to achieve sustainability
in the global coronavirus vaccine market.
Methodology Followed for Calculation of Market Size:
Market Size by Value: Market size, in terms of value, for the
year 2020 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key
opinion leaders/stakeholders, such as coronavirus vaccine
manufacturers, channel partners, market influencers & end
users, industry experts, and other industry participants.
The team interviewed more than 15 – 20 coronavirus vaccine
manufacturers, 100 – 120 end users, and 15 – 20 industry experts
and other value chain stakeholders in the global coronavirus
vaccine market to obtain the overall market size from 2016 to 2020,
which was validated by the Delphi technique. Taking standard
deviation into consideration, the market size was averaged out, to
arrive at the market size data during 2016-2020.
Research Methodology
Respondents were asked about the current and future market
growth rates, market shares by infection type, by vaccine type, by
product type, by route of administration, by patient type, by end
user, by company and by each region. Removing the outlier
responses, the geometric mean of growth estimates and provider wise
revenue shares generated across various segments were considered,
to arrive at the final revenue shares. Revenue shares generated
across various type were further triangulated from other
stakeholders.
Methodology Followed for Calculation of Market Shares:
Market shares by infection type, by vaccine type, by product
type, by route of administration, by patient type, by end user, by
company and by each region were calculated based on the responses
received through primary surveys with industry experts, in which
the respondents were asked about the market shares or revenue
generated from various types of coronavirus vaccine. The final
shares were calculated by taking the geometric mean of the
responses gathered from key opinion leaders after eliminating the
outliers.
Methodology Followed for Forecasting:
TechSci Research performed periodical checks on data collected
through the surveys with logic checks and analyzed the survey
results in SPSS/Tableau Software.
Data triangulation techniques were applied to fill the gaps and
to present a more meaningful picture of the market. To forecast
global coronavirus vaccine market, TechSci Research used various
forecast techniques such as:
Moving Average
Time Series Analysis
Regression Analysis
Econometric and Judgmental Analysis
Research Methodology
TechSci Research used its own forecast tool, which is based on
the growth of various allied industries in respective regions.
TechSci Research also used the impact analysis during short, medium
and long term period to estimate the demand and to reach accurate
market numbers. It should be noted that the figures compiled are
only for the organized market including market share data. The
currency used in the report is the United States Dollar (USD), with
the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary
SourcesModerna, Inc.Pfizer Inc..Johnson & Johnson SASinopharm
Group Company Ltd.AstraZeneca PLCSerum Institute of India Pvt
Ltd.Bharat Biotech International Ltd.Sinovac Biotech Ltd.Sanofi
SAGlaxoSmithKline PLCNovavax, Inc.Airway Therapeutics, Inc.Cadila
Healthcare Ltd.CanSino Biologics Inc.Mitsubishi Chemical Holdings
CorporationEubiologics Co. Ltd.United Biomedical Inc.Merck &
Co., Inc.CureVac N.V.Inovio Pharmaceuticals, Inc.World
BankInternational Monetary Fund (IMF)TechSci Research Proprietary
Database & Knowledge RepositoryCompany Annual Reports Industry
MagazinesIndustry ReportsNews DailiesCredible Paid Databases
Industry Brief
According to TechSci Research report, “Global Coronavirus
Vaccine Market By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV),
By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid
Vaccine, Protein Based Vaccine and Others), By Product Type
(Monovalent Vaccine v/s Multivariant Vaccine), By Route of
Administration (Intramuscular, Oral, Intranasal), By Patient Type
(Adults v/s Pediatric), By End User (Hospitals, Clinics, Research
Institutes, Others), By Region, Forecast & Opportunities,
2026”, the global coronavirus vaccine market is expected to rise in
2021 and 2022 in value terms to reach USD91325.46 million in 2021.
The global coronavirus vaccine market is expected to grow at a
robust rate during the forecast period on account of the increasing
research and development activities related to manufacture of
coronavirus vaccine by the major companies and research
laboratories around the globe. Additionally, increasing funding
& grants by various governments around the world for
development of vaccine to contain coronavirus, is expected to
foster the market over the next few years. Furthermore, increasing
healthcare spending and rising need to protect the population from
the outbreak are positively impacting the growth of market. The
major challenge that will hamper the growth of coronavirus vaccine
will be the post vaccination’s side-effects. After the
administration of COVAXIN developed by Bharat Biotech International
Ltd and COVISHIELD by Serum Institute of India, swelling at the
injection site, fever, body ache, nausea, rashes, arm stiffness
etc. are the common side effects post vaccination. The efficacy
rate of the coronavirus vaccine will be the deciding factor for
choosing the vaccine, the efficacy rate of SPUTNIK developed by
Gamaleya Research Institute is reported to be 91.6%, the efficacy
rate of COVISHIELD is 70.4% and that of COVAXIN is 78-81%. Today,
several COVID-19 vaccines have been approved to administer into
public. In India, COVAXIN phase II/III clinical trials for
pediatric children falling in the age group of 2-18 has begun.
Medicago along with GSK and Dynavax is developing plant based
adjuvant vaccine (VIR-7831), which is under phase III trial.
The global coronavirus vaccine market is segmented based on
infection type, vaccine type, product type, route of
administration, patient type, end user, company, and region. Based
on vaccine type, the market can be categorized into virus vaccine,
viral vector vaccine, nucleic acid vaccine, protein based vaccine
and others. The virus vaccine is expected to hold the largest
market share during forecast period since this is the most
traditional method used for the development of vaccines. While the
protein based coronavirus vaccine is expected to register the
highest growth since the most of the vaccines that are under
development and have entered the clinical trials are protein based
ones. Based on patient type, the market can be bifurcated into
pediatric and adult. The adult segment is expected to dominate the
market since mostly the adults especially the geriatric population,
is getting affected by the COVID-19 disease. However, in the
forecast period pediatric patient type will be leading the
market.
Some of the major competitors in the market are Moderna, Inc.,
Johnson & Johnson SA, Pfizer Inc., Sinopharm Group Company
Ltd., AstraZeneca PLC, Serum Institute of India Pvt Ltd., Bharat
Biotech International Ltd., Sinovac Biotech Ltd., Sanofi SA,
GlaxoSmithKline PLC, Novavax, Inc., Airway Therapeutics, Inc.,
Cadila Healthcare Ltd., CanSino Biologics Inc., Mitsubishi Chemical
Holdings Corporation, Eubiologics Co. Ltd., United Biomedical Inc.,
Merck & Co., Inc., CureVac N.V., Inovio Pharmaceuticals, Inc.
The companies are focusing on extensive research and development
activities to stay competitive in the market.
The companies operating in the market are using organic
strategies such as product launches, mergers, and collaborations to
boost their share. Bharat Biotech has collaborated with the
University of Wisconsin Madison and US-based company FluGen to
develop a vaccine, Coro-Flu, against COVID-19.
“North America is expected to dominate the coronavirus vaccine
market during the forecast period owing to the increasing R&D
investments for the development of a potential vaccine against the
coronavirus in the region. Additionally, supportive government
policies & schemes are further expected to propel the market.
Furthermore, the presence of major players such as Moderna, Inc.,
Pfizer Inc., Novavax, Inc., among others, who are aggressively
developing the vaccine, is expected to create lucrative
opportunities for the market growth through 2026.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based
global management consulting firm.
Sample Data - Snapshot
Global Coronavirus Vaccine Market Size, By Value (USD Million),
2016–2026F
CAGR BY VALUE: XX%
CAGR BY VALUE: XX%
Asia-Pacific Coronavirus Vaccine Market Share, By Infection
Type, By Value, 2016–2026F
India Coronavirus Vaccine Market Share, By Product Type, By
Value, 2016–2026F
By Value (USD Million)
201620202021E2026F56789101112131415
SARS-CoV-2
201620172018201920202021E2022F2023F2024F2025F2026F0.40.40.40.40.40.40.40.40.40.40.4SARS-CoV
201620172018201920202021E2022F2023F2024F2025F2026F0.30.30.30.30.30.30.30.30.30.30.3MERS-CoV
201620172018201920202021E2022F2023F2024F2025F2026F0.30.30.30.30.30.30.30.30.30.30.3
Monovalent Vaccine
201620172018201920202021E2022F2023F2024F2025F2026F0.50.50.50.50.50.50.50.50.50.50.5Multivariant
Vaccine
201620172018201920202021E2022F2023F2024F2025F2026F0.50.50.50.50.50.50.50.50.50.50.5
Report Ordering
License Type PriceElectronic Access - Single User
License$4450Electronic Access - Multi-User License$5450Custom
Research License$9450
Report Price
To View Sample OR Purchase Report
Report Name: GLOBAL CORONAVIRUS VACCINE MARKET
FORECAST & OPPORTUNITIES
2016 – 2026
About Us & Disclaimer
TechSci Research is a global market research and consulting
company with offices in the US, UK and India. TechSci Research
provides market research reports in number of areas to
organizations. The company uses innovative business models that
focus on improving productivity, while ensuring creation of
high-quality reports. The proprietary forecasting models use
various analyses of both industry-specific and macroeconomic
variables on a state-by-state basis to produce a unique ‘bottom-up’
model of a country, regional and global industry prospects.
Combined with the detailed analysis of company activity and
industry trends, the result is a uniquely rich evaluation of the
opportunities available in the market.
Related Reports
Global Mammography Devices Market By Product Type (Full-field
Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis),
By Technology (Digital v/s Analog) By End User (Hospitals &
Clinics, Diagnostic Centers, Others), By Region, Competition,
Forecast & Opportunities, 2026.
Global 3D Mobile C-Arm Market By Application (Orthopedics,
Trauma, Cardiovascular, Urology, Gastroenterology, Neurology,
Others) By End Users (Hospitals, Specialty Clinics, Ambulatory
Surgical Clinics) By Region, Competition Forecast &
Opportunities, 2026.
The contents of this report are based on information generally
available to the public from sources believed to be reliable. No
representation is made that it is timely, accurate or complete.
TechSci Research has taken due care and caution in compilation of
data as this has been obtained from various sources including which
it considers reliable and firsthand. However, TechSci Research does
not guarantee the accuracy, adequacy or completeness of any
information and it is not responsible for any errors or omissions
or for the results obtained from the use of such information and
especially states that it has no financial liability whatsoever to
the subscribers / users of this report. The information herein,
together with all estimates and forecasts, can change without
notice. All the figures provided in this document are indicative of
relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will
require prior approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: [email protected] www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: [email protected] www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital Region, U.P. -
India
Tel: +91-120-4523900
Email: [email protected] www.techsciresearch.com
